Maric Irina, Pittaluga Stefania, Dale Janet K, Niemela Julie E, Delsol Georges, Diment Judith, Rosai Juan, Raffeld Mark, Puck Jennifer M, Straus Stephen E, Jaffe Elaine S
Hematopathology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Am J Surg Pathol. 2005 Jul;29(7):903-11. doi: 10.1097/01.pas.0000157997.61177.08.
Autoimmune lymphoproliferative syndrome (ALPS) is an inherited disorder associated with defects in Fas-mediated apoptosis, characterized most often by childhood onset of lymphadenopathy, splenomegaly, hypergammaglobulinemia, and autoimmune phenomena. Children with sinus histiocytosis with massive lymphadenopathy (SHML) have a somewhat similar clinical phenotype in which prominent adenopathy also is associated with hypergammaglobulinemia, and autoimmune phenomena are reported in 10-15% of cases. We observed histopathological features of SHML in the lymph nodes of some of our ALPS patients, further suggesting an association between these two disorders. We, thus, reviewed the lymph nodes from 44 patients ALPS type Ia, all of whom were confirmed to have germline mutations in the TNFRSF6 gene encoding Fas (CD95/Apo-1). Eighteen of 44 (41%) patients had a histiocytic proliferation resembling SHML. The affected patients included 15 males and 3 females ranging in age from 11 months to 30 years at the time of the LN biopsy. The lymph nodes contained S-100+ histiocytes with characteristic nuclear features of SHML, and showed evidence of emperipolesis in both hematoxylin and eosin (H and E) and immunostained sections. The extent of the histiocytic proliferation was variable, being confluent in 2 cases, multifocal in 13, and only evident as isolated SHML-type histiocytes in 3. In lymph nodes without confluent SHML changes, increased numbers of CD3+CD4-CD8+ (double negative) alphabeta T-cells, also negative for CD45RO, a feature of ALPS, could be identified in the paracortex. Furthermore, because SHML shares many clinical features with ALPS, we sought evidence of ALPS in sporadic SHML. We attempted to sequence TNFRSF6 DNA from archived tissue of 14 cases of Rosai-Dorfman disease. Full sequencing of the gene was successful in 4 of the cases; no mutations were identified. Nevertheless, our observations suggest that histologic features of SHML are part of the pathologic spectrum of ALPS type Ia. It remains to be determined if some cases of apparently sporadic SHML may be associated with heritable defects in Fas-mediated apoptosis.
自身免疫性淋巴细胞增生综合征(ALPS)是一种与Fas介导的细胞凋亡缺陷相关的遗传性疾病,其特征通常为儿童期起病的淋巴结病、脾肿大、高球蛋白血症和自身免疫现象。伴有巨大淋巴结病的窦性组织细胞增生症(SHML)患儿具有 somewhat 相似的临床表型,其中显著的淋巴结病也与高球蛋白血症相关,且10% - 15%的病例报告有自身免疫现象。我们在一些ALPS患者的淋巴结中观察到了SHML的组织病理学特征,进一步提示这两种疾病之间存在关联。因此,我们回顾了44例Ia型ALPS患者的淋巴结,所有患者均被证实编码Fas(CD95/Apo - 1)的TNFRSF6基因存在种系突变。44例患者中有18例(41%)出现了类似SHML的组织细胞增生。受影响的患者包括15名男性和3名女性,在进行淋巴结活检时年龄从11个月至30岁不等。淋巴结含有具有SHML特征性核特征的S - 100 +组织细胞,并且在苏木精和伊红(H&E)染色切片及免疫染色切片中均显示有血细胞吞噬现象。组织细胞增生的程度各不相同,2例为融合性,13例为多灶性,3例仅表现为孤立的SHML型组织细胞。在没有融合性SHML改变的淋巴结中,在副皮质区可识别出数量增加的CD3 + CD4 - CD8 +(双阴性)αβ T细胞,这些细胞对CD45RO也呈阴性,这是ALPS的一个特征。此外,由于SHML与ALPS有许多共同的临床特征,我们在散发性SHML中寻找ALPS的证据。我们试图对14例罗萨伊 - 多尔夫曼病存档组织中的TNFRSF6 DNA进行测序。4例病例成功完成了该基因全长测序;未发现突变。然而,我们的观察结果表明,SHML的组织学特征是Ia型ALPS病理谱的一部分。目前尚有待确定一些明显散发性SHML病例是否可能与Fas介导的细胞凋亡中的遗传性缺陷相关。